• Acceleron Pharma : Oppenheimer adjusts pt to $160 from $141, maintains outperform rating
  • Accenture : Wedbush adjusts pt to $330 from $280 on upbeat fiscal q3 results, maintains outperform rating
  • Aveva: HSBC upgraded stock from hold to buy with a target of GBp 4345.
  • Colgate-Palmolive : UBS assumes coverage of colgate-palmolive with buy rating, $95 price target
  • Comcast : UBS changes price target to $60 from $56, maintains neutral rating
  • Darden Restaurants : Wolfe Research lifts pt to $160 from $129, maintains outperform rating
  • DoorDash : KGI Securities starts doordash at hold with $200 price target
  • Eli Lilly and Company : Mizuho adjusts price target to $250 from $216, maintains buy rating
  • Equinix, Inc. (REIT) : Oppenheimer lifts price target to $880 from $820, maintains outperform rating
  • The Hershey Company: Consumer Edge raises pt to $178 from $163, maintains equal-weight rating
  • Intel Corporation: Bernstein maintains its advice to sell. The target price remains unchanged at $43.
  • Microsoft : KB Securities lifts pt to $300 from $250, maintains buy rating
  • Nike, Inc: Jefferies research applies a Buy rating. The target price is revised upwards from USD 200 to USD 192.
  • Procter & Gamble : UBS assumes coverage with neutral rating, $138 price target
  • PureCycle Technologies : Oppenheimer adjusts pt to $28 from $24 after investor day, maintains outperform rating
  • Raven Industries : CJS Securities downgrades raven industries to market perform from market outperform
  • Roku : Masterlink Securities lifts pt to $500 from $430, maintains buy rating
  • Vitec: Jefferies remains Buy with a price target raised from GBp 1625 to GBp 1665.